A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac®) in patients with perennial rhinitis. II. Immunological aspects

E. A. Pastorello, C. Ortolani, C. Incorvaia, L. Farioli, M. Italia, V. Pravettoni, R. J. Harris, H. K. Watson, O. J. Corrado, R. J. Davies, C. Zanussi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In a 2-year double-blind placebo controlled study an immunological evaluation was carried out on 33 patients (15 males, 18 females, mean age 29.2 years) with mite-induced perennial rhinitis who were submitted to specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus. The behaviour of IgE, IgG, IgG1 and IgG4 antibodies specific to D. pteronyssinus and its major allergen Der p1 was characterized by assessment of their changes in serum, and changes in IgG in nasal secretions during the treatment. The placebo-treated patients did not show any significant variation in the levels of specific antibodies, while in the actively treated patients we found: a statistically significant decrease (P <0.005) of specific IgE, a statistically significant increase of specific IgG (P <0.005), IgG1 (P <0.005) and IgG4 (P <0.005) in serum and a statistically significant increase (P <0.001) of specific IgG in nasal secretions. The IgG response showed an early relative predominance of the IgG1 subclass and a late absolute predominance of IgG4 subclass, that confirmed the model of IgG4 restriction in prolonged allergen stimulation. No correlation was found between immunological and clinical data.

Original languageEnglish
Pages (from-to)505-514
Number of pages10
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume45
Issue number7
Publication statusPublished - 1990

Fingerprint

Dermatophagoides pteronyssinus
Rhinitis
Double-Blind Method
Immunoglobulin G
Nose
Allergens
Immunoglobulin E
conjuvac
alginic acid
Placebos
Antibodies
Mites
Serum
Immunotherapy

Keywords

  • alginates
  • desensitization
  • IgA
  • IgE
  • IgG
  • immunologic
  • mites

ASJC Scopus subject areas

  • Immunology

Cite this

A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac®) in patients with perennial rhinitis. II. Immunological aspects. / Pastorello, E. A.; Ortolani, C.; Incorvaia, C.; Farioli, L.; Italia, M.; Pravettoni, V.; Harris, R. J.; Watson, H. K.; Corrado, O. J.; Davies, R. J.; Zanussi, C.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 45, No. 7, 1990, p. 505-514.

Research output: Contribution to journalArticle

Pastorello, E. A. ; Ortolani, C. ; Incorvaia, C. ; Farioli, L. ; Italia, M. ; Pravettoni, V. ; Harris, R. J. ; Watson, H. K. ; Corrado, O. J. ; Davies, R. J. ; Zanussi, C. / A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac®) in patients with perennial rhinitis. II. Immunological aspects. In: Allergy: European Journal of Allergy and Clinical Immunology. 1990 ; Vol. 45, No. 7. pp. 505-514.
@article{6e8a10487e724670bb5fcafadbdf6be3,
title = "A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac{\circledR}) in patients with perennial rhinitis. II. Immunological aspects",
abstract = "In a 2-year double-blind placebo controlled study an immunological evaluation was carried out on 33 patients (15 males, 18 females, mean age 29.2 years) with mite-induced perennial rhinitis who were submitted to specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus. The behaviour of IgE, IgG, IgG1 and IgG4 antibodies specific to D. pteronyssinus and its major allergen Der p1 was characterized by assessment of their changes in serum, and changes in IgG in nasal secretions during the treatment. The placebo-treated patients did not show any significant variation in the levels of specific antibodies, while in the actively treated patients we found: a statistically significant decrease (P <0.005) of specific IgE, a statistically significant increase of specific IgG (P <0.005), IgG1 (P <0.005) and IgG4 (P <0.005) in serum and a statistically significant increase (P <0.001) of specific IgG in nasal secretions. The IgG response showed an early relative predominance of the IgG1 subclass and a late absolute predominance of IgG4 subclass, that confirmed the model of IgG4 restriction in prolonged allergen stimulation. No correlation was found between immunological and clinical data.",
keywords = "alginates, desensitization, IgA, IgE, IgG, immunologic, mites",
author = "Pastorello, {E. A.} and C. Ortolani and C. Incorvaia and L. Farioli and M. Italia and V. Pravettoni and Harris, {R. J.} and Watson, {H. K.} and Corrado, {O. J.} and Davies, {R. J.} and C. Zanussi",
year = "1990",
language = "English",
volume = "45",
pages = "505--514",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac®) in patients with perennial rhinitis. II. Immunological aspects

AU - Pastorello, E. A.

AU - Ortolani, C.

AU - Incorvaia, C.

AU - Farioli, L.

AU - Italia, M.

AU - Pravettoni, V.

AU - Harris, R. J.

AU - Watson, H. K.

AU - Corrado, O. J.

AU - Davies, R. J.

AU - Zanussi, C.

PY - 1990

Y1 - 1990

N2 - In a 2-year double-blind placebo controlled study an immunological evaluation was carried out on 33 patients (15 males, 18 females, mean age 29.2 years) with mite-induced perennial rhinitis who were submitted to specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus. The behaviour of IgE, IgG, IgG1 and IgG4 antibodies specific to D. pteronyssinus and its major allergen Der p1 was characterized by assessment of their changes in serum, and changes in IgG in nasal secretions during the treatment. The placebo-treated patients did not show any significant variation in the levels of specific antibodies, while in the actively treated patients we found: a statistically significant decrease (P <0.005) of specific IgE, a statistically significant increase of specific IgG (P <0.005), IgG1 (P <0.005) and IgG4 (P <0.005) in serum and a statistically significant increase (P <0.001) of specific IgG in nasal secretions. The IgG response showed an early relative predominance of the IgG1 subclass and a late absolute predominance of IgG4 subclass, that confirmed the model of IgG4 restriction in prolonged allergen stimulation. No correlation was found between immunological and clinical data.

AB - In a 2-year double-blind placebo controlled study an immunological evaluation was carried out on 33 patients (15 males, 18 females, mean age 29.2 years) with mite-induced perennial rhinitis who were submitted to specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus. The behaviour of IgE, IgG, IgG1 and IgG4 antibodies specific to D. pteronyssinus and its major allergen Der p1 was characterized by assessment of their changes in serum, and changes in IgG in nasal secretions during the treatment. The placebo-treated patients did not show any significant variation in the levels of specific antibodies, while in the actively treated patients we found: a statistically significant decrease (P <0.005) of specific IgE, a statistically significant increase of specific IgG (P <0.005), IgG1 (P <0.005) and IgG4 (P <0.005) in serum and a statistically significant increase (P <0.001) of specific IgG in nasal secretions. The IgG response showed an early relative predominance of the IgG1 subclass and a late absolute predominance of IgG4 subclass, that confirmed the model of IgG4 restriction in prolonged allergen stimulation. No correlation was found between immunological and clinical data.

KW - alginates

KW - desensitization

KW - IgA

KW - IgE

KW - IgG

KW - immunologic

KW - mites

UR - http://www.scopus.com/inward/record.url?scp=0025066114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025066114&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 505

EP - 514

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 7

ER -